Antibiotics Active Pharmaceutical Ingredient Market

Antibiotics Active Pharmaceutical Ingredient Market contains market size and forecasts of Antibiotics Active Pharmaceutical Ingredient (API) in global, including the following market information:

Global Antibiotics Active Pharmaceutical Ingredient (API) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Antibiotics Active Pharmaceutical Ingredient (API) Market Sales, 2017-2022, 2023-2028, (Tons)

Global top five Antibiotics Active Pharmaceutical Ingredient (API) companies in 2021 (%)

The global Antibiotics Active Pharmaceutical Ingredient (API) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Penicillin Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antibiotics Active Pharmaceutical Ingredient (API) include Sandoz International, Centrient Pharmaceuticals, CordenPharma International, ACS DOBFAR, Nanjing Dorra Pharmaceutical Technology, DAEWOONG PHARMACEUTICAL, Parabolic Drugs, Penam Laboratories and ASIATIC DRUGS & PHARMACEUTICALS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Antibiotics Active Pharmaceutical Ingredient (API) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antibiotics Active Pharmaceutical Ingredient (API) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Antibiotics Active Pharmaceutical Ingredient (API) Market Segment Percentages, by Type, 2021 (%)

Penicillin Antibiotics

Cephalosporins

Carbapenem Antibiotics

Global Antibiotics Active Pharmaceutical Ingredient (API) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Antibiotics Active Pharmaceutical Ingredient (API) Market Segment Percentages, by Application, 2021 (%)

Pharmaceutical Companies

Contract Manufacturing Organizations (CMOs)

Contract Development & Manufacturing Organizations (CDMOs)

Global Antibiotics Active Pharmaceutical Ingredient (API) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Antibiotics Active Pharmaceutical Ingredient (API) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antibiotics Active Pharmaceutical Ingredient (API) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Antibiotics Active Pharmaceutical Ingredient (API) revenues share in global market, 2021 (%)

Key companies Antibiotics Active Pharmaceutical Ingredient (API) sales in global market, 2017-2022 (Estimated), (Tons)

Key companies Antibiotics Active Pharmaceutical Ingredient (API) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Sandoz International

Centrient Pharmaceuticals

CordenPharma International

ACS DOBFAR

Nanjing Dorra Pharmaceutical Technology

DAEWOONG PHARMACEUTICAL

Parabolic Drugs

Penam Laboratories

ASIATIC DRUGS & PHARMACEUTICALS

Fresenius Kabi

The United Laboratories International Holdings

Aurobindo Pharma

Unimark Remedies

Savior Lifetec

Shenzhen Haibin Pharmaceutical

Sterile India

Zhejiang Jiuzhou Pharmaceutical

Kyongbo Pharm